Structure- and ligand-based virtual screening identifies new scaffolds for inhibitors of the oncoprotein MDM2.

ABSTRACT: A major challenge in the field of ligand discovery is to identify chemically useful fragments that can be developed into inhibitors of specific protein-protein interactions. Low molecular weight fragments (with molecular weight less than 250 Da) are likely to bind weakly to a protein's surface. Here we use a new virtual screening procedure which uses a combination of similarity searching and docking to identify chemically tractable scaffolds that bind to the p53-interaction site of MDM2. The binding has been verified using capillary electrophoresis which has proven to be an excellent screening method for such small, weakly binding ligands.

SUBMITTER: Houston DR 

PROVIDER: S-EPMC4401541 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature